[Circulatory support with venoarterial ECMO in a patient with biventricular Takotsubo cardiomyopathy]

Emmanuel A Lazcano-Díaz1, Francisco J González-Ruiz2, Diego Sarre-Álvarez3

  • 1Servicio de Terapia Intensiva Cardiovascular, Instituto Nacional de Cardiología Ignacio Chávez de México, Ciudad de México, México.

Insights

Takotsubo cardiomyopathy, a transient heart condition, can lead to severe cardiogenic shock. This case highlights biventricular Takotsubo cardiomyopathy requiring advanced circulatory support like ECMO.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery

Background:

  • Takotsubo cardiomyopathy (TTC) is characterized by acute, transient ventricular dysfunction, often triggered by emotional or physical stress.
  • It typically presents as regional left ventricular systolic dysfunction, but can be biventricular in up to 30% of cases.
  • Severe cases may lead to refractory cardiogenic shock, necessitating circulatory assist devices.

Observation:

  • A young patient underwent pulmonary valve replacement with a bioprosthetic valve.
  • Seven weeks post-surgery, she presented with pericardial effusion and tamponade physiology due to post-pericardiotomy syndrome.
  • A pericardial window was performed, during which biventricular Takotsubo cardiomyopathy developed.

Findings:

  • The biventricular Takotsubo cardiomyopathy resulted in severe cardiogenic shock.
  • This was associated with severe mitral and tricuspid regurgitation.
  • The patient was refractory to medical management and intra-aortic balloon pump (IABP) support.

Implications:

  • The case underscores the potential for Takotsubo cardiomyopathy to occur in complex surgical settings.
  • Venoarterial extracorporeal membrane oxygenation (VA-ECMO) was crucial for hemodynamic support.
  • This highlights the importance of considering advanced circulatory support in refractory cardiogenic shock secondary to Takotsubo cardiomyopathy.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
270
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
196
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
297
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
322
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
164